Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) belongs to the group of
Betacoronaviruses. The SARS-CoV-2 is closely related to SARS-CoV-1 and probably …

Almost simultaneously, several studies reported the emergence of novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages characterized by distinct …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel evolutionary
divergent RNA virus, is responsible for the present devastating COVID-19 pandemic. To …

Abstract A novel Coronavirus, 2019‐nCoV, has been identified as the causal pathogen of an
ongoing epidemic, with the first cases reported in Wuhan, China, last December 2019, and …

Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China, in December 2019 and has been rapidly spreading worldwide. Although the …

Since the outbreak of SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, the viral
genome has acquired numerous mutations with the potential to increase transmission. One …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of COVID
19, continues to evolve since its first emergence in December 2019. Using the complete …

A new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated with
human to human transmission and extreme human sickness has been as of late announced …

Abstract Coronavirus disease of 2019 (COVID-19), which originated in China in 2019,
shows mild cold and pneumonia symptoms that can occasionally worsen and result in …

Background A novel coronavirus of zoonotic origin (2019-nCoV) has recently been identified
in patients with acute respiratory disease. This virus is genetically similar to SARS …